Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
organ rejection
MedTech
Thermo Fisher unveils test for dosing of antirejection drug
Thermo Fisher Scientific is launching a new test to help doctors dose patients with a common antirejection drug after organ transplant surgery.
Natalie Missakian
Feb 27, 2026 5:20am
Immunosuppressant antibody curbs chronic transplant rejection
Apr 24, 2023 11:05am
MIT engineers develop shape-shifting artificial pancreas implant
Aug 8, 2022 10:28am
Talaris pulls off $150M IPO to tackle organ rejection
May 7, 2021 10:35am
ITBMed bags $67M to advance ex-MedImmune asset
Apr 4, 2018 11:00am
United Therapeutics backs TAI, pens organ monitoring pact
Jan 9, 2018 12:03pm
